CoolTech develops transnasal cooling technology for non-invasive fever control and neuroprotection.
CoolTech has raised $500K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2025.
CoolTech's investors include TEDCO, Abell Foundation.
CoolTech is headquartered in Toronto, United States.
CoolTech develops transnasal cooling technology for non-invasive fever control and neuroprotection.
CoolTech is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"CoolTech — Funding & Investors." VCBacked, September 10, 2025, https://www.vcbacked.co/company/cooltech. Accessed August 7, 2026.
VCBacked. (2025). CoolTech — Funding & Investors. Retrieved August 7, 2026, from https://www.vcbacked.co/company/cooltech
{{cite web |title=CoolTech — Funding & Investors |url=https://www.vcbacked.co/company/cooltech |website=VCBacked |access-date=August 7, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated